HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klemens Schütte Selected Research

CNS 5161

7/2007Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Klemens Schütte Research Topics

Disease

1Polyneuropathies (Polyneuropathy)
09/2011
1Diabetic Neuropathies (Diabetic Neuropathy)
09/2011
1Pain (Aches)
07/2007
1Headache (Headaches)
07/2007
1Nervous System Diseases (Neurological Disorders)
07/2007
1Neuralgia (Stump Neuralgia)
07/2007

Drug/Important Bio-Agent (IBA)

1Thioctic Acid (Lipoic Acid)IBA
09/2011
1AntioxidantsIBA
09/2011
1N-Methylaspartate (NMDA)IBA
07/2007
1CNS 5161IBA
07/2007
1Excitatory Amino Acid AntagonistsIBA
07/2007